Table 2.
Age of exposure to rotavirus infection in young children globally, as assessed by exposure in the placebo groups of vaccine studies.
Sero-positive status |
Sero-positive status |
||
---|---|---|---|
Region | Country | at 6–8 weeks of age1 | at 20–24 weeks of age |
Africa | South Africa/Malawi | 11% | 17% |
Ghana/Kenya/Mali | 2% | 20% | |
Asia | Bangladesh | 15% | 35% |
India | 26% | 26% | |
Latin | Brazil/Mexico/Venezuela | 2% | 13% |
America | Multiple countries3 | 4% | 15% |
Europe | Finland | 0% | 0% |
Multiple countries | 2% | 9% | |
United States | 0% | 9% |
1Sero-positivity assessed by to anti-rotavirus IgA antibody titres
2Blood was drawn 4– 8 weeks post last vaccine administration
3Argentina, Brazil, Chile, Colombia, Dominica Republic, Honduras, Mexico, Nicaragua, Panama, Peru, Venezuela
4Czech Republic, Finland, France, Germany, Italy, Spain
Footnote: adapted from references 55 and 56